This inventor holds 1 USPTO granted patent. Top assignee: Exonhit Therapeutics, Sa. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Kevin M McGowan: Innovator in Prostate Cancer Therapy
Introduction
Kevin M McGowan is a notable inventor based in North Potomac, MD (US). He has made significant contributions to the field of cancer research, particularly in the area of prostate cancer therapy. His work focuses on identifying specific genes that can be targeted for treatment, diagnosis, or prevention of prostate cancer.
Latest Patents
Kevin M McGowan holds a patent titled "Prostate specific genes and the use thereof as targets for prostate cancer therapy." This patent identifies genes that are upregulated in human prostate tumor tissues, along with the corresponding proteins. These genes and their antigens are recognized as suitable targets for the treatment and diagnosis of prostate cancer. He has 1 patent to his name.
Career Highlights
Kevin is currently associated with Exonhit Therapeutics, a company dedicated to advancing cancer therapies. His role at the company allows him to apply his innovative ideas in a practical setting, contributing to the development of new treatment options for patients.
Collaborations
Throughout his career, Kevin has worked alongside esteemed colleagues such as Matthew P Pando and Richard Einstein. Their collaborative efforts have furthered research in the field of cancer therapy.
Conclusion
Kevin M McGowan's work in identifying prostate-specific genes represents a significant advancement in cancer research. His contributions are paving the way for more effective therapies for prostate cancer, ultimately benefiting patients and the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile